| 000 | 01718 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518083903.0 | ||
| 264 | 0 | _c20210212 | |
| 008 | 202102s 0 0 eng d | ||
| 022 | _a1557-8976 | ||
| 024 | 7 |
_a10.1089/vim.2019.0157 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOmatola, Cornelius Arome | |
| 245 | 0 | 0 |
_aCoinfection of Human Immunodeficiency Virus-Infected Patients with Hepatitis B Virus in Lokoja, North Central Nigeria. _h[electronic resource] |
| 260 |
_bViral immunology _c06 2020 |
||
| 300 |
_a391-395 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Retroviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCoinfection _xepidemiology |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHealth Risk Behaviors |
| 650 | 0 | 4 |
_aHepatitis B _xepidemiology |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNigeria _xepidemiology |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeroepidemiologic Studies |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aOkolo, Martin-Luther Oseni | |
| 700 | 1 | _aAdaji, David Moses | |
| 700 | 1 | _aMofolorunsho, Charles Kehinde | |
| 700 | 1 | _aAbraham Oyiguh, Joseph | |
| 700 | 1 | _aZige, Douye Victor | |
| 700 | 1 | _aAkpala, Ndah Sumaila | |
| 700 | 1 | _aOcholi Samson, Sunday | |
| 773 | 0 |
_tViral immunology _gvol. 33 _gno. 5 _gp. 391-395 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/vim.2019.0157 _zAvailable from publisher's website |
| 999 |
_c30608815 _d30608815 |
||